Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A decision-support system for flow cytometry immunophenotyping.

Adam L Asare1, Jason S Ellis, Charles W Caldwell

  • 1Department of Pathology and Anatomical Sciences, School of Medicine, University of Missouri-Columbia, USA.

American Journal of Clinical Pathology
|October 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Communications medicine·2026
Same author

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Communications medicine·2025
Same author

HuR ablation destabilizes <i>Foxp3</i> mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype.

Frontiers in immunology·2025
Same author

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Nature medicine·2024
Same author

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Nature medicine·2024
Same author

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same journal

Communication patterns among surgical pathologists: a retrospective review of ideal strategies in a tertiary care setting.

American journal of clinical pathology·2026
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
See all related articles

The Flow Cytometry Workstation (FCW) system reduced technical and clerical errors in CD4+ testing. This clinical flow cytometry tool also identified specimen processing issues impacting data accuracy.

Area of Science:

  • Clinical Laboratory Science
  • Immunology
  • Biomedical Informatics

Background:

  • Clinical flow cytometry requires robust quality assurance for accurate diagnostic and research data.
  • Existing laboratory management systems may lack integrated decision support for complex immunophenotyping.
  • Automated quality assurance functions are crucial for validating flow cytometry data.

Purpose of the Study:

  • To evaluate the Flow Cytometry Workstation (FCW) system for reducing technical and clerical errors in CD4+ testing.
  • To assess the FCW's capability in identifying trends and patterns within flow cytometric data for research.
  • To establish a foundation for quality improvement in clinical flow cytometry.

Main Methods:

  • Development of the Flow Cytometry Workstation (FCW) decision-support system.

Related Experiment Videos

  • Implementation of automated quality assurance functions, including user-defined antibody sums and delta checks.
  • Retrospective analysis of a 10-year flow cytometry dataset using FCW quality assurance checks.

    • Main Results:

    • The FCW significantly reduced technical and clerical errors in CD4+ testing within its first two years (P = .003).
    • Application of user-defined quality assurance checks (e.g., CD2+ + CD20+ = 95% +/- 5%) on historical data.
    • Discovery of a significant relationship between specimen processing methods and out-of-range results, with a dramatic decrease from 58.11% in 1993 to 2% in 1996 (P1 < .001).

    Conclusions:

    • The Flow Cytometry Workstation (FCW) system effectively reduces errors in clinical flow cytometry, enhancing data reliability.
    • The FCW facilitates outcomes-based research by uncovering critical data trends and laboratory process improvements.
    • The FCW serves as a valuable platform for advanced laboratory management and quality improvement in flow cytometry.